Stockscreener 앱 받기
0.7174
0.04%
0.0003
시장 영업 전:
.72
0.0026
+0.36%
전일 마감가:
$0.7171
열려 있는:
$0.7253
하루 거래량:
64,683
Relative Volume:
0.13
시가총액:
$5.34M
수익:
-
순이익/손실:
$-16.28M
주가수익비율:
-0.0516
EPS:
-13.91
순현금흐름:
$-13.75M
1주 성능:
+0.89%
1개월 성능:
-1.18%
6개월 성능:
-37.62%
1년 성능:
-84.57%
1일 변동 폭
$0.6901
$0.7253
1주일 범위
$0.69
$0.7299
52주 변동 폭
$0.65
$7.50
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
명칭
Pasithea Therapeutics Corp
전화
(702) 514-4174
주소
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
KTTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
0.7174 | 5.29M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Pasithea Therapeutics Corp 주식(KTTA)의 최신 뉴스
Is Pasithea Therapeutics Corp. Equity Warrant reversing from oversold territory2025 Price Momentum & Weekly High Return Stock Forecasts - Newser
Options Data Show Bullish Bias in Pasithea Therapeutics Corp.Portfolio Value Report & Consistent Profit Focused Trading Strategies - newsyoung.net
How to integrate Pasithea Therapeutics Corp. into portfolio analysis toolsStop Loss & Daily Stock Trend Reports - Newser
What’s the recovery path for long term holders of Pasithea Therapeutics Corp.July 2025 Closing Moves & Safe Capital Growth Stock Tips - Newser
Historical volatility pattern of Pasithea Therapeutics Corp. Equity Warrant visualizedQuarterly Trade Review & Growth Focused Entry Reports - Newser
Heatmap analysis for Pasithea Therapeutics Corp. Equity Warrant and competitorsTrade Risk Report & Daily Stock Trend Reports - Newser
Leading vs lagging indicators on Pasithea Therapeutics Corp. performance2025 Price Momentum & Risk Controlled Stock Alerts - Newser
Is Pasithea Therapeutics Corp. Equity Warrant stock entering bullish territoryJuly 2025 Opening Moves & Reliable Price Action Trade Plans - Newser
Using data models to predict Pasithea Therapeutics Corp. stock movementPortfolio Performance Report & AI Based Trade Execution Alerts - Newser
What institutional flow reveals about Pasithea Therapeutics Corp.Short Setup & Verified Swing Trading Watchlists - Newser
Can Pasithea Therapeutics Corp. Equity Warrant Overcome Bearish SentimentForecast Cut & Short-Term Trading Alerts - Newser
Visual trend scoring systems applied to Pasithea Therapeutics Corp. Equity WarrantEarnings Beat & Safe Swing Trade Setups - Newser
What’s the recovery path for long term holders of Pasithea Therapeutics Corp. Equity Warrant2025 Market Outlook & Intraday High Probability Setup Alerts - Newser
How to escape a deep drawdown in Pasithea Therapeutics Corp. Equity WarrantMarket Activity Report & Safe Entry Momentum Tips - Newser
How to manage a losing position in Pasithea Therapeutics Corp.Jobs Report & Verified Chart Pattern Signals - Newser
Price action breakdown for Pasithea Therapeutics Corp. Equity WarrantGap Down & Free Long-Term Investment Growth Plans - Newser
How moving averages guide Pasithea Therapeutics Corp. Equity Warrant tradingQuarterly Investment Review & Real-Time Buy Zone Alerts - Newser
How to monitor Pasithea Therapeutics Corp. with trend dashboardsMarket Movers & Daily Volume Surge Trade Alerts - Newser
How to read the order book for Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Analyst Calls & Daily Technical Forecast Reports - Newser
Will Pasithea Therapeutics Corp. Equity Warrant stock go up soonMarket Risk Report & Real-Time Volume Trigger Notifications - Newser
Pasithea Therapeutics Corp.’s Beta Climbs After Market Volatility2025 Market Outlook & Risk Controlled Daily Plans - 선데이타임즈
What data driven models say about Pasithea Therapeutics Corp.’s futureJuly 2025 Drop Watch & Consistent Growth Stock Picks - Newser
Will Pasithea Therapeutics Corp. Equity Warrant stock benefit from interest rate changesCPI Data & Daily Oversold Bounce Ideas - Newser
Published on: 2025-08-19 02:19:11 - Newser
Visualizing Pasithea Therapeutics Corp. Equity Warrant stock with heatmaps2025 Valuation Update & Fast Exit Strategy with Risk Control - Newser
Applying big data sentiment scoring on Pasithea Therapeutics Corp. Equity WarrantJuly 2025 Selloffs & Safe Entry Point Identification - Newser
Using flow based indicators on Pasithea Therapeutics Corp. Equity WarrantDollar Strength & Low Drawdown Momentum Ideas - Newser
Why Pasithea Therapeutics Corp. stock attracts strong analyst attention2025 Winners & Losers & AI Driven Stock Reports - Newser
Using Python tools to backtest Pasithea Therapeutics Corp. strategiesSell Signal & Fast Exit and Entry Strategy Plans - Newser
Published on: 2025-08-18 02:44:16 - Newser
Can trapped investors hope for a rebound in Pasithea Therapeutics Corp.Portfolio Performance Report & Fast Entry High Yield Tips - Newser
Published on: 2025-08-17 06:01:40 - Newser
Pasithea Therapeutics Corp. Equity Warrant Flashes Rebound Signal in Oversold ConditionJuly 2025 News Drivers & Accurate Intraday Trading Signals - metal.it
Pasithea Therapeutics Corp (KTTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pasithea Therapeutics Corp 주식 (KTTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
May 12 '25 |
Sale |
0.82 |
960 |
792 |
40,001 |
1.38%
0.27%
자본화:
|
볼륨(24시간):